Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
5.58%Interest Expense Margin
VS
Market
Sector
Industry
History
$ 2.29Close
$ 1 - $ 2.65 52-Week Range
Ticker Information
Ticker
AYTUCompany Name
AYTU BIOPHARMA INCSector
HealthcareIndustry
Drug Manufacturers - Specialty & GenericExchange
NASDAQAYTU BIOPHARMA INC - Interest Expense Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
AYTU - Int. Exp. % Historical data
| Date | Interest Expense | Interest Expense Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 3.7M | 5.58% | $ 66.38M |
| 3/31/2025 | $ 7.76M | 11.22% | $ 69.22M |
| 12/31/2024 | $ 6.87M | 9.98% | $ 68.76M |
| 9/30/2024 | $ 5.79M | 7.67% | $ 75.48M |
| 6/30/2024 | $ 4.79M | 5.92% | $ 81M |
| 3/31/2024 | $ 0 | 0% | $ 93.76M |
| 12/31/2023 | $ 0 | 0% | $ 98.5M |
| 9/30/2023 | $ 0 | 0% | $ 101.84M |
| 6/30/2023 | $ 0 | 0% | $ 107.4M |
| 3/31/2023 | $ 0 | 0% | $ 104.11M |
Key Performance Insights, Last 5 Years
- AYTU BIOPHARMA INC's latest trailing twelve months (TTM) Int. Exp. % stands at 0%.
- Over the past 5 years, AYTU BIOPHARMA INC's average Int. Exp. % has been 2.02%.
- The median Int. Exp. % for AYTU BIOPHARMA INC during this period was 0%
- AYTU BIOPHARMA INC reached its highest Int. Exp. % over the past 5 years at 11.22%.
- The lowest Int. Exp. % recorded by AYTU BIOPHARMA INC in the same timeframe 0%
AYTU BIOPHARMA INC's Int. Exp. % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Int. Exp. % Benchmarks
Similar metrics to Revenues:
- Interest Expense - [Income Statement] Interest expense is the cost incurred by a business for borrowing funds.
- Research and Development Margin - [Calculation] The company’s research and development expenses [RnD] expressed as a percentage of [Revenue].
- Stock Based Compensation Margin - [Calculation] The company’s stock-based compensation [SbComp] expressed as a percentage of [Revenue].
- Operating Cash Flow Margin - [Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].
- Depreciation and Amortization Margin - [Calculation] The company’s deprecation and amortization [DepAmor] expressed as a percentage of [Revenue].
Definition of Interest Expense Margin
[Calculation] The company’s interest expenses [IntExp] expressed as a percentage of [Revenue].Int. Exp. / Revenues
(=) Int. Exp. % Int. Exp. % for AYTU BIOPHARMA INC is calculated as follows: Int. Exp. [ $ 0 ] / Revenues [ $ 39.71M ]
(=) Int. Exp. % [ 0% ] AYTU - Interest Expense Margin, Last 5 years
0%
Minimum
Sep 30, 2020
11.22%
Maximum
Mar 31, 2025
2.02%
Average
0%
Median
Int. Exp. % Benchmark AnalysisMarket
The chart above depicts the distribution of Int. Exp. % for companies in the Total Stock Market. The average Int. Exp. % of the companies is 1.63% with a standard deviation of 2.2%.
The following table provides additional summary stats:
Int. Exp. % in the Market:
| filtered constituents | 3.15K |
|---|---|
| min | -4.94% |
| max | 8.49% |
| average | 1.63% |
| median | 0.79% |
| std | 2.2% |